Effectiveness and safety of intermittent preventive treatment for malaria using either dihydroartemisinin-piperaquine or artesunate-amodiaquine in reducing malaria related morbidities and improving cognitive ability in school-aged children in Tanzania: A study protocol for a controlled randomised trial

Geofrey Makenga, Vito Baraka, Filbert Francis, Swabra Nakato, Samwel Gesase, George Mtove, Rashid Madebe, Edna Kyaruzi, Daniel T R Minja, John P A Lusingu, Jean-Pierre Van Geertruyden, Geofrey Makenga, Vito Baraka, Filbert Francis, Swabra Nakato, Samwel Gesase, George Mtove, Rashid Madebe, Edna Kyaruzi, Daniel T R Minja, John P A Lusingu, Jean-Pierre Van Geertruyden

Abstract

Background: In high transmission settings, up to 70% of school-aged children harbour malaria parasites without showing any clinical symptoms. Thus, epidemiologically, school aged children act as a substantial reservoir for malaria transmission. Asymptomatic Plasmodium infections induce inflammation leading to iron deficiency anaemia. Consequently, anaemia retards child growth, predisposes children to other diseases and reduces cognitive potential that could lead to poor academic performance. School aged children become increasingly more vulnerable as compared to those aged less than five years due to delayed acquisition of protective immunity. None of the existing Intermittent Preventive Treatment (IPT) strategies is targeting school-aged children. Here, we describe the study protocol of a clinical trial conducted in north-eastern Tanzania to expand the IPT by assessing the effectiveness and safety of two antimalarial drugs, Dihydroartemisinin-Piperaquine (DP) and Artesunate-Amodiaquine (ASAQ) in preventing malaria related morbidities in school-aged children (IPTsc) living in a high endemic area.

Methods/design: The trial is a phase IIIb, individual randomized, open label, controlled trial enrolling school children aged 5-15 years, who receive either DP or ASAQ or control (no drug), using a "balanced block design" with the "standard of care" arm as reference. The interventional treatments are given three times a year for the first year. A second non-interventional year will assess possible rebound effects. Sample size was estimated to 1602 school children (534 per group) from selected primary schools in an area with high malaria endemicity. Thick and thin blood smears (to measure malaria parasitaemia using microscope) were obtained prior to treatment at baseline, and will be obtained again at month 12 and 20 from all participants. Haemoglobin concentration using a haemoglobinometer (HemoCue AB, Sweden) will be measured four monthly. Finger-prick blood (dried bloodspot-DBS) prepared on Whatman 3 M filter paper, will be used for sub-microscopic malaria parasite detection usingPCR, detect markers of drug resistance (using next generation sequencing (NGS) technology), and malaria serological assays (using enzyme-linked immunosorbent assay, ELISA). To determine the benefit of IPTsc on cognitive and psychomotor ability test of everyday attention for children (TEA-Ch) and a '20 m Shuttle run' respectively, will be conducted at baseline, month 12 and 20. The primary endpoints are change in mean haemoglobin from baseline concentration and reduction in clinical malaria incidence at month 12 and 20 of follow up. Mixed design methods are used to assess the acceptability, cost-effectiveness and feasibility of IPTsc as part of a more comprehensive school children health package. Statistical analysis will be in the form of multilevel modelling, owing to repeated measurements and clustering effect of participants.

Discussion: Malaria intervention using IPTsc strategy may be integrated in the existing national school health programme. However, there is limited systematic evidence to assess the effectiveness and operational feasibility of this approach. School-aged children are easily accessible in most endemic malaria settings. The evidence from this study will guide the implementation of the strategy to provide complementary approach to reduce malaria related morbidity, anaemia and contribute to the overall burden reduction.

Trial registration: Clinicaltrials.gov: NCT03640403, registered on Aug 21, 2018, prospectively registered.Url https://www.clinicaltrials.gov/ct2/show/NCT03640403?term=NCT03640403&rank=1.

Keywords: Anaemia; Artesunate-amodiaquine; Cognitive ability; Dihydroartemisinin-piperaquine; Effectiveness; Malaria; Randomized controlled trial.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2020 The Authors.

Figures

Fig. 1
Fig. 1
Trial flow chart. IPTsc = intermittent preventive treatment in school-aged children; DP = dihydroartemisinin-piperaquine; ASAQ = Artesunate Amodiaquine; AE = adverse event; SAE = serious adverse event; ITT = intention-to-treat analysis; PP = per-protocol analysis.
Fig. 2
Fig. 2
A map of Tanzania showing study site location.

References

    1. World Health Organization World malaria report 2019. 2019. Geneva.
    1. Nankabirwa J., Brooker S.J., Clarke S.E., Fernando D., Gitonga C.W., Schellenberg D., Greenwood B. Malaria in school-age children in Africa: an increasingly important challenge. Trop. Med. Int. Health. 2014;19:1294–1309. doi: 10.1111/tmi.12374.
    1. Trial P., Nankabirwa J.I., Wandera B., Amuge P., Kiwanuka N., Dorsey G., Rosenthal P.J., Brooker S.J., Staedke S.G., Kamya M.R. 2014. Impact of Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine on Malaria in Ugandan Schoolchildren : A, 58.
    1. Gametocyte W., Group S. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy : a systematic review and meta- analysis of individual patient data. 2016.
    1. Busula A.O., Bousema T., Mweresa C.K., Masiga D., Logan J.G., Sauerwein R.W., Verhulst N.O., Takken W., de Boer J.G. Gametocytemia and attractiveness of Plasmodium falciparum-infected Kenyan children to Anopheles gambiae mosquitoes. J. Infect. Dis. 2017;216:291–295. doi: 10.1093/infdis/jix214.
    1. Lamptey H., Ofori M.F., Kusi K.A., Adu B., Owusu-Yeboa E., Kyei-Baafour E., Arku A.T., Bosomprah S., Alifrangis M., Quakyi I.A. The prevalence of submicroscopic Plasmodium falciparum gametocyte carriage and multiplicity of infection in children, pregnant women and adults in a low malaria transmission area in Southern Ghana 11 Medical and Health Sciences 1108 Medical Microbiology 1. Malar. J. 2018;17:331. doi: 10.1186/s12936-018-2479-y.
    1. Clarke S.E., Rouhani S., Diarra S., Saye R., Bamadio M., Jones R., Traore D., Traore K., Jukes M.C., Thuilliez J., Brooker S., Roschnik N., Sacko M. Impact of a malaria intervention package in schools on Plasmodium infection, anaemia and cognitive function in schoolchildren in Mali: a pragmatic cluster-randomised trial. BMJ Glob. Heal. 2017;2 doi: 10.1136/bmjgh-2016-000182.
    1. Clarke S.E., Jukes M.C., Njagi J.K., Khasakhala L., Cundill B., Otido J., Crudder C., Estambale B.B., Brooker S. Effect of intermittent preventive treatment of malaria on health and education in school children: a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:127–138. doi: 10.1016/S0140-6736(08)61034-X.
    1. Mtove G., Mugasa J.P., Messenger L.A., Malima R.C., Mangesho P., Magogo F., Plucinski M., Hashimu R., Matowo J., Shepard D., Batengana B., Cook J., Emidi B., Halasa Y., Kaaya R., Kihombo A., Lindblade K.A., Makenga G., Mpangala R., Mwambuli A., Mzava R., Mziray A., Olang G., Oxborough R.M., Seif M., Sambu E., Samuels A., Sudi W., Thomas J., Weston S., Alilio M., Binkin N., Gimnig J., Kleinschmidt I., McElroy P., Moulton L.H., Norris L., Ruebush T., Venkatesan M., Rowland M., Mosha F.W., Kisinza W.N. The effectiveness of non-pyrethroid insecticide-treated durable wall lining to control malaria in rural Tanzania: study protocol for a two-armed cluster randomized trial. BMC Publ. Health. 2016;16:633. doi: 10.1186/s12889-016-3287-3.
    1. Matangila J.R., Doua J.Y., Linsuke S., Madinga J., Inocenci Da Luz R., Van Geertruyden J.P., Lutumba P. Malaria, schistosomiasis and soil transmitted helminth burden and their correlation with anemia in children attending primary schools in kinshasa, democratic republic of Congo. PloS One. 2014;9 doi: 10.1371/journal.pone.0110789.
    1. Hotez P.J., Kamath A. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl. Trop. Dis. 2009;3 doi: 10.1371/journal.pntd.0000412.
    1. Boivin M.J., Sikorskii A., Lopez I.F., Escudero H.R., Muhindo M., Kapisi J., Bigira V., Bass J.K., Opoka R.O., Nakasujja N., Kamya M., Dorsey G. Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children. Malar. J. 2016:1–12. doi: 10.1186/s12936-016-1266-x.
    1. Halliday K.E., Karanja P., Turner E.L., Okello G., Njagi K., Dubeck M.M., Allen E., Jukes M.C.H., Brooker S.J. Vol. 17. 2012. pp. 532–549. (Plasmodium falciparum , anaemia and cognitive and educational performance among school children in an area of moderate malaria transmission : baseline results of a cluster randomized trial on the coast of Kenya).
    1. Brooker S., Okello G., Njagi K., Dubeck M.M., Halliday K.E., Inyega H., Jukes M.C.H. 2010. Improving Educational Achievement and Anaemia of School Children : Design of a Cluster Randomised Trial of School-Based Malaria Prevention and Enhanced Literacy Instruction in Kenya; pp. 1–14.
    1. Mboera L.E.G., Senkoro K.P., Rumisha S.F., Mayala B.K., Shayo E.H., Mlozi M.R.S. Plasmodium falciparum and helminth coinfections among schoolchildren in relation to agro-ecosystems in Mvomero District, Tanzania. Acta Trop. 2011;120:95–102. doi: 10.1016/j.actatropica.2011.06.007.
    1. Kinung S., Magnussen P., Kaatano G., Olsen A. Infection with schistosoma mansoni has an effect on quality of life , but not on physical fitness in schoolchildren in mwanza region. North-Western Tanzania : A Cross-Sectional Study. 2016;8:1–14. doi: 10.1371/journal.pntd.0005257.
    1. Kinung’hi S.M., Mazigo H.D., Dunne D.W., Kepha S., Kaatano G., Kishamawe C., Ndokeji S., Angelo T., Nuwaha F. Coinfection of intestinal schistosomiasis and malaria and association with haemoglobin levels and nutritional status in school children in Mara region, Northwestern Tanzania: a cross-sectional exploratory study. BMC Res. Notes. 2017;10:583. doi: 10.1186/s13104-017-2904-2.
    1. Who . 2018. World malaria report. 2018. ISBN: 978 92 4 156565 3.
    1. Ric Price A.N.J.W., Ois Nosten Franc, Simpson Julie A., Luxemburger Christine, Phaipun Lucy, Ter Kuile Feiko, Van Vugt Michele, Chongsuphajaisiddhi Tan. Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children. Parasitology. 2004;129:255–262. doi: 10.1017/S0031182004005669.
    1. Stepniewska K., Price R.N., Sutherland C.J., Drakeley C.J., Von Seidlein L., Nosten F., White N.J. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar. J. 2008;7:1–22. doi: 10.1186/1475-2875-7-249.
    1. Price R.N., Simpson J.A., Nosten F., Luxemburger C., Hkirjaroen L., Kuile F.T., Chongsuphajaisiddhi T., White N.J. Factors contributing to anemia after uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 2001;65:614–622. doi: 10.4269/ajtmh.2001.65.614.
    1. Taylor W.R., Widjaja H., Basri H., Tjitra E., Ohrt C., Taufik T., Baso S., Hoffman S.L., Richie T.L. Haemoglobin dynamics in Papuan and non-Papuan adults in northeast Papua, Indonesia, with acute, uncomplicated vivax or falciparum malaria. Malar. J. 2013;12:1–9. doi: 10.1186/1475-2875-12-209.
    1. Bousema J.T., Schneider P., Gouagna L.C., Drakeley C.J., Tostmann A., Houben R., Githure J.I., Ord R., Sutherland C.J., Omar S.A., Sauerwein R.W. 2006. Moderate Effect of Artemisinin-Based Combination Therapy on Transmission of Plasmodium Falciparum; pp. 1151–1159.
    1. Who . third ed. 2015. Guideline for Treatment of Malaria.
    1. Menendez C., Fleming A.F., Alonso P.L., Menendez C., Fleming A., Alonso P. Malaria-related Anaemia. 2000:4758. doi: 10.1016/s0169-4758(00)01774-9.
    1. Nankabirwa J., Cundill B., Clarke S., Kabatereine N., Rosenthal P.J., Brooker S., Staedke S.G. Vol. 5. 2010. (Efficacy , safety , and tolerability of three regimens for prevention of Malaria : a randomized , placebo- controlled trial in Ugandan schoolchildren).
    1. Matangila J.R., Doua J.Y., Mitashi P., Inocêncio R., Lutumba P., Pierre J., Geertruyden V. International Journal of Antimicrobial Agents Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine ( SP ) and SP plus piperaquine in Democratic Republic of the Congo : a randomised controlled trial. Int. J. Antimicrob. Agents. 2017;49:339–347. doi: 10.1016/j.ijantimicag.2016.11.017.
    1. Cisse B., Cairns M., Faye E., NDiaye O., Faye B., Cames C., Cheng Y., NDiaye M., Lô A.C., Simondon K., Trape J.F., Faye O., NDiaye J.L., Gaye O., Greenwood B., Milligan P. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PloS One. 2009;4 doi: 10.1371/journal.pone.0007164.
    1. Bojang K., Akor F., Bittaye O., Conway D., Bottomley C., Milligan P., Greenwood B. A randomised trial to compare the safety, tolerability and efficacy of three drug combinations for intermittent preventive treatment in children. PloS One. 2010;5:1–9. doi: 10.1371/journal.pone.0011225.
    1. Ahorlu C.K., Koram K.A., Seakey A.K., Weiss M.G. Vol. 7. 2009. pp. 1–7. (Effectiveness of combined intermittent preventive treatment for children and timely home treatment for malaria control).
    1. Nankabirwa J.I., Conrad M.D., Legac J., Tukwasibwe S., Tumwebaze P., Wandera B., Brooker S.J., Staedke S.G., Kamya M.R., Nsobya S.L., Dorsey G., Rosenthal J. Intermittent preventive treatment with dihydroartemisinin- piperaquine in Ugandan schoolchildren selects for Plasmodium falciparum transporter polymorphisms that modify. Drug Sensitivity. 2016;60:5649–5654. doi: 10.1128/AAC.00920-16.Address.
    1. Okell L.C., Reiter L.M., Ebbe L.S., Baraka V., Bisanzio D., Watson O.J., Bennett A., Verity R., Gething P., Roper C., Alifrangis M. 2018. Emerging Implications of Policies on Malaria Treatment : Genetic Changes in the Pfmdr-1 Gene Affecting Susceptibility to Artemether – Lumefantrine and Artesunate – Amodiaquine in Africa; pp. 1–12.
    1. Envelope Sealed, Simple randomisation service: a blocked randomisation list. n.d. accessed February 3, 2018.
    1. Ministry of health and Social Welfare . 2013. National Guidelines for Diagnosis and Treatment of Malaria; p. 145.
    1. Birthweight R., Minja D.T.R., Schmiegelow C., Mmbando B., Boström S., Oesterholt M., Magistrado P., Pehrson C., John D., Salanti A., Luty A.J.F., Lemnge M., Theander T., Lusingu J., Alifrangis M. Plasmodium falciparum mutant haplotype infection during pregnancy associated with. Emerg. Infect. Dis. 2013;19 doi: 10.3201/eid1909.130133.
    1. Baraka V., Ishengoma D.S., Fransis F., Minja D.T.R., Madebe R.A., Ngatunga D., Van Geertruyden J.-P. High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania. Malar. J. 2015;14:439. doi: 10.1186/s12936-015-0977-8.
    1. Doua J., Matangila J., Lutumba P., Van geertruyden J.-P. Intermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial. Trials. 2013;14:311. doi: 10.1186/1745-6215-14-311.
    1. Karema C., Fanello C.I., Van Overmeir C., Van geertruyden J.P., van Doren W., Ngamije D., D'Alessandro U. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Trans. R. Soc. Trop. Med. Hyg. 2006 doi: 10.1016/j.trstmh.2006.01.001.
    1. Denis M.B., Davis T.M.E., Hewitt S., Incardona S., Nimol K., Fandeur T., Poravuth Y., Lim C., Socheat D. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin. Infect. Dis. 2002 doi: 10.1086/344647.
    1. Thera M.A., Kone A.K., Tangara B., Diarra E., Niare S., Dembele A., Sissoko M.S., Doumbo O.K. School-aged children based seasonal malaria chemoprevention using artesunate-amodiaquine in Mali. Parasite Epidemiol. Control. 2018;3:96–105. doi: 10.1016/j.parepi.2018.02.001.
    1. Ahorlu C.K., Koram K.A., Seake-kwawu A., Weiss M.G. 2011. Two-year Evaluation of Intermittent Preventive Treatment for Children ( IPTc ) Combined with Timely Home Treatment for Malaria Control in Ghana; pp. 1–7.
    1. Opoku E.C., Olsen A., Browne E., Hodgson A., Awoonor-williams J.K., Yelifari L., Williams J., Magnussen P. Corrigendum: impact of combined intermittent preventive treatment of malaria and helminths on anaemia, sustained attention, and recall in Northern Ghanaian schoolchildren. Glob. Health Action. 2016;9:32197. doi: 10.3402/gha.v9.32197. doi: 10.3402/GHA.V9.33548. Glob. Health Action. 9 (2016) 1–11.
    1. Baron I.S. Test of everyday attention for children; the thames valley test company, bury st. Edmunds, suffolk, UK. Child Neuropsychol. 2001;7:190–195. doi: 10.1076/chin.7.3.190.8742.
    1. Manly T., Robertson I.H., Anderson V. The differential assessment of children's attention: the Test of Everyday Attention for Children (TEA-Ch), normative sample and ADHD performance. JCPP (J. Child Psychol. Psychiatry) 2001;42:1065–1081.
    1. Khairnar K., Martin D., Lau R., Ralevski F., Pillai D.R. Multiplex real-time quantitative PCR, microscopy and rapid diagnostic immuno-chromatographic tests for the detection of Plasmodium spp: performance, limit of detection analysis and quality assurance. Malar. J. 2009;8:1–17. doi: 10.1186/1475-2875-8-284.
    1. Weiner B.J. Vol. 9. 2009. pp. 1–9. (A theory of organizational readiness for change).
    1. Glasgow R.E., Vogt T.M., Boles S.M. 1999. Evaluating the Public Health Impact of Health Promotion Interventions : the RE-AIM Framework; p. 89.
    1. Proctor E., Silmere H., Raghavan R., Hovmand P., Aarons G., Bunger A., Griffey R., Hensley M. 2011. Outcomes for Implementation Research : Conceptual Distinctions , Measurement Challenges , and Research Agenda; pp. 65–76.
    1. Nilsen P. 2015. Making Sense of Implementation Theories , Models and Frameworks; pp. 1–13.
    1. Coulibaly J.T., Fu T., Knopp S., Hattendorf J., Stefanie J., Righetti A., Glinz D., Yao A.K., Pu U., Goran K.N. 2011. Effect of Schistosomiasis and Soil-Transmitted Helminth ^ Te Infections on Physical Fitness of School Children in Co D ’ Ivoire; p. 5.
    1. Siza J.E., Kaatano G.M., Chai J., Eom K.S., Rim H., Yong T., Min D., Chang S.Y., Ko Y., Changalucha J.M. Prevalence of schistosomes and soil-transmitted helminths and morbidity associated with schistosomiasis among adult population in lake victoria basin. Tanzania. 2015;53:525–533.
    1. Mangold, Manson Koay, Stephens Regner, Thomson Peterson. Kaul, Real-time PCR for detection and identification of Plasmodium spp. J. Clin. Microbiol. 2005;43:2435–2440. doi: 10.1128/JCM.43.5.2435.
    1. Witkowski B., Duru V., Khim N., Ross L.S., Saintpierre B., Beghain J., Chy S., Kim S., Ke S., Kloeung N., Eam R., Khean C., Ken M., Loch K., Bouillon A., Domergue A., Ma L., Bouchier C., Leang R., Huy R., Nuel G., Barale J.C., Legrand E., Ringwald P., Fidock D.A., Mercereau-Puijalon O., Ariey F., Ménard D. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study. Lancet Infect. Dis. 2017;17:174–183. doi: 10.1016/S1473-3099(16)30415-7.
    1. Amato R., Lim P., Miotto O., Neal A.T., Sreng S., Suon S., Drury E. Vol. 17. 2017. pp. 164–173. (Europe PMC Funders Group Genetic markers associated with dihydroartemisinin – piperaquine failure in Plasmodium falciparum malaria in Cambodia : a genotype-phenotype association study).
    1. Nag S., Dalgaard M.D., Kofoed P.E., Ursing J., Crespo M., Andersen L.O.B., Aarestrup F.M., Lund O., Alifrangis M. High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology. Sci. Rep. 2017;7:1–13. doi: 10.1038/s41598-017-02724-x.
    1. Idris Z.M., Chan C.W., Kongere J., Hall T., Logedi J., Gitaka J., Drakeley C., Kaneko A. Naturally acquired antibody response to Plasmodium falciparum describes heterogeneity in transmission on islands in Lake Victoria. Sci. Rep. 2017;7:9123. doi: 10.1038/s41598-017-09585-4.
    1. Corran P.H., Cook J., Lynch C., Leendertse H., Manjurano A., Griffin J., Cox J., Abeku T., Bousema T., Ghani A.C., Drakeley C., Riley E. Dried blood spots as a source of anti-malarial antibodies for epidemiological studies, Malar. J. 2008;7:195. doi: 10.1186/1475-2875-7-195.
    1. Harris P.a., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J.G. Research Electronic Data Capture (REDCap) - a metadata driven methodology and workflow process for providing translational research informatict support. J. Biomed. Inf. 2009;42:377–381. doi: 10.1016/j.jbi.2008.08.010.Research.
    1. Noordzij M., Tripepi G., Dekker F.W., Zoccali C., Tanck M.W., Jager K.J. 2010. CME Series Sample Size Calculations : Basic Principles and Common Pitfalls; pp. 1388–1393.
    1. UCSF . Paired T-test); 2018. Sample Size for Before-After Study. accessed September 5, 2018.
    1. Weaver M.A. 2009. Sample Size Calculations for Survival Analysis; pp. 1–22.
    1. Newton P.N., Schellenberg D., Ashley E.A., Ravinetto R., Green M.D., Ter Kuile F.O., Tabernero P., White N.J., Guerin P.J. Quality assurance of drugs used in clinical trials: proposal for adapting guidelines. BMJ. 2015;350 doi: 10.1136/bmj.h602. 0–4.
    1. Doua Y.J., Dominicus H., Mugwagwa J., Gombe S.M., Nwokike J. Scarce quality assurance documentation in major clinical trial registries for approved medicines used in post-marketing clinical trials. Trials. 2019;20:1–6. doi: 10.1186/s13063-019-3277-8.
    1. TMDA, reigered human medicinal products. n.d. accessed January 10, 2019.
    1. Temperley M., Mueller D.H., Njagi J.K., Akhwale W., Clarke S.E., Jukes M.C.H., Estambale B.B.A., Brooker S. Costs and cost-effectiveness of delivering intermittent preventive treatment through schools in western Kenya. Malar. J. 2008;7:1–9. doi: 10.1186/1475-2875-7-196.
    1. Breman J.G. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am. J. Trop. Med. Hyg. 2001;64:1–11. doi: 10.4269/ajtmh.2001.64.1.
    1. Bijker E.M., Sauerwein R.W. Enhancement of naturally acquired immunity against malaria by drug use. J. Med. Microbiol. 2012;61:904–910. doi: 10.1099/jmm.0.041277-0.
    1. O'Meara W.P., Breman J.G., McKenzie F.E. The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi) Malar. J. 2005;4:1–10. doi: 10.1186/1475-2875-4-33.
    1. Gurarie D., McKenzie F.E. Dynamics of immune response and drug resistance in malaria infection. Malar. J. 2006;5:86. doi: 10.1186/1475-2875-5-86.
    1. Doolan D.L., Dobaño C., Baird J.K. Acquired immunity to malaria. Clin. Microbiol. Rev. 2009;22:13–36. doi: 10.1128/CMR.00025-08.
    1. Romi G.M.R., Razaiarimanga M.C., Raharimanga R., Rakotondraibe E.M., Ranaivo l.H., Pietra V., Raveloson A. Vol. 66. 2002. pp. 2–6. (Impact of the malaria control campaign ( 1993 – 1998 ) in the highlands of Madagascar : parasitological and entomological data).
    1. Bousema T., Drakeley C., Gesase S., Hashim R., Magesa S., Mosha F., Otieno S., Carneiro I., Cox J., Msuya E., Kleinschmidt I., Maxwell C., Greenwood B., Riley E., Sauerwein R., Chandramohan D., Gosling R. Identification of hot spots of malaria transmission for targeted malaria control. J. Infect. Dis. 2010;201:1764–1774. doi: 10.1086/652456.
    1. Oyola S.O., Ariani C.V., Hamilton W.L., Kekre M., Amenga-Etego L.N., Ghansah A., Rutledge G.G., Redmond S., Manske M., Jyothi D., Jacob C.G., Otto T.D., Rockett K., Newbold C.I., Berriman M., Kwiatkowski D.P. Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification. Malar. J. 2016;15:597. doi: 10.1186/s12936-016-1641-7.
    1. Ngondi J.M., Ishengoma D.S., Doctor S.M., Thwai K.L., Keeler C., Mkude S., Munishi O.M., Willilo R.A., Lalji S., Kaspar N., Kitojo C., Paxton L.A., Hathaway N.J., Bailey J.A., Juliano J.J., Meshnick S.R., Gutman J. Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling and next-generation sequencing. Malar. J. 2017;16:236. doi: 10.1186/s12936-017-1886-9.
    1. MoHCDDEC, neglected tropical diseases control program in Tanzania, NTDCP website. 2017. Last edit: 2016-04-21 09:20:42. accessed August 14, 2017.
    1. Mazigo H.D., Nuwaha F., Kinung S.M., Morona D., De Moira A.P., Wilson S., Heukelbach J., Dunne D.W. 2012. Epidemiology and Control of Human Schistosomiasis in Tanzania; pp. 1–20.
    1. W.H.O. (Who) Crossing the Billion. Preventive chemotherapy for neglected tropical diseases. 2017.
    1. NIMR Data transfer agreement. 2007.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe